Ospedale Maggiore San Giovanni Bosco   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Turin Italy (1955)

Organization Overview

First Clinical Trial
1999
NCT00473213
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Ospedale Mafggiore San Giovanni Bosco,Divisione di Neurologia Piazza Donatori del Sangue, 3 10154 Torino | Ospedale Maggiore - Diabetologia Malattie Metaboliche - Chieri | Ospedale Maggiore di Milano IRCCS Policlinico | Ospedale Maggiore Policlinico Mangiagalli e Regina Elena

Active Ingredients

Drugs in Phase 4 Trials (1)

diclofenac (voltaren) (1 trial)

Drugs in Phase 3 Trials (4)

linagliptin (tradjenta) (1 trial)

peginterferon beta-1a (Plegridy) (1 trial)

propranolol (inderal) (1 trial)

spk-843 (1 trial)

Drugs in Phase 2 Trials (1)

neridronic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aspergillosis (Phase 3)

beta-Thalassemia (Phase 2)

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Cryptococcosis (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Hemorrhage (Phase 4)

Multiple Sclerosis (Phase 3)

Mycoses (Phase 3)

Osteoporosis (Phase 2)

Premature Birth (Phase 3)

Retinal Diseases (Phase 3)

Retinopathy of Prematurity (Phase 3)

Sclerosis (Phase 3)

Subarachnoid Hemorrhage (Phase 4)

Thalassemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6